Statistics for Development of resistance to imatinib, a tyrosine kinase inhibitor, in chronic myeloid leukemia cell line-K562: Role of COX-2 and MDR1

Total visits

views
Development of resistance to imatinib, a tyrosine kinase inhibitor, in chronic myeloid leukemia cell line-K562: Role of COX-2 and MDR1 2

Total visits per month

views
December 2025 0
January 2026 0
February 2026 0
March 2026 0
April 2026 1
May 2026 0
June 2026 0

File Visits

views
25

Top country views

views
China 1
Russia 1

Top city views

views
Moscow 1